Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas C Hanff

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Plos One|April 23, 2021
Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US VeteransCatherine G Derington, Jordana B Cohen, April F Mohanty, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Integrative Clinical-Molecular Modeling Identifies <i>LRRN4CL</i> as a Determinant of Structural and Functional Myocardial ImprovementEzra Johnson, Joseph R Visker, Ben J Brintz, et al.
The Lancet. Respiratory Medicine|January 10, 2021
Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trialJordana B Cohen, Thomas C Hanff, Preethi William, et al.
JAMA Cardiology|February 5, 2025
Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure-A Call to ActionShannon M Dunlay, Sean P Pinney, Anuradha Lala, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Plos One|April 23, 2021
Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US VeteransCatherine G Derington, Jordana B Cohen, April F Mohanty, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
Integrative Clinical-Molecular Modeling Identifies <i>LRRN4CL</i> as a Determinant of Structural and Functional Myocardial ImprovementEzra Johnson, Joseph R Visker, Ben J Brintz, et al.
The Lancet. Respiratory Medicine|January 10, 2021
Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trialJordana B Cohen, Thomas C Hanff, Preethi William, et al.
JAMA Cardiology|February 5, 2025
Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure-A Call to ActionShannon M Dunlay, Sean P Pinney, Anuradha Lala, et al.
Pageof 8